# Jie Shi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/jie-shi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 5,754 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 34 |
| i10-index | 92 |
| Last Known Institution | Qingdao University |
| OpenAlex ID | https://openalex.org/A5100682847 |
| ORCID iD | 0000-0001-6072-7031 |
| Works | 236 |

## Researcher papers

- [Flavonoids in Food and Their Health Benefits](https://scholariq.org/papers/flavonoids-in-food-and-their-health-benefits/)
- [Effect of Antiviral Treatment With Nucleotide/Nucleoside Analogs on Postoperative Prognosis of Hepatitis B Virus–Related Hepatocellular Carcinoma: A Two-Stage Longitudinal Clinical Study](https://scholariq.org/papers/effect-of-antiviral-treatment-with-nucleotide-nucleoside-analogs-on/)
- [Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled Study](https://scholariq.org/papers/neoadjuvant-three-dimensional-conformal-radiotherapy-for-resectable/)
- [Postoperative Adjuvant Transcatheter Arterial Chemoembolization After R0 Hepatectomy Improves Outcomes of Patients Who have Hepatocellular Carcinoma with Microvascular Invasion](https://scholariq.org/papers/postoperative-adjuvant-transcatheter-arterial-chemoembolization-after-r0/)
- [A new classification for hepatocellular carcinoma with portal vein tumor thrombus](https://scholariq.org/papers/a-new-classification-for-hepatocellular-carcinoma-with-portal-vein-tumor/)
- [An Eastern Hepatobiliary Surgery Hospital/Portal Vein Tumor Thrombus Scoring System as an Aid to Decision Making on Hepatectomy for Hepatocellular Carcinoma Patients With Portal Vein Tumor Thrombus](https://scholariq.org/papers/an-eastern-hepatobiliary-surgery-hospital-portal-vein-tumor-thrombus-scoring/)
- [Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial](https://scholariq.org/papers/adjuvant-sintilimab-in-resected-high-risk-hepatocellular-carcinoma-a-randomized/)
- [Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition)](https://scholariq.org/papers/guidelines-for-diagnosis-and-treatment-of-hepatocellular-carcinoma-with-portal/)
- [All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancer](https://scholariq.org/papers/all-trans-retinoic-acid-potentiates-the-chemotherapeutic-effect-of-cisplatin-by/)
- [A Comparative Study of Antiviral Therapy After Resection of Hepatocellular Carcinoma in the Immune-Active Phase of Hepatitis B Virus Infection](https://scholariq.org/papers/a-comparative-study-of-antiviral-therapy-after-resection-of-hepatocellular/)
- [Genomic Landscape and Tumor Mutational Burden Determination of Circulating Tumor DNA in Over 5,000 Chinese Patients with Lung Cancer](https://scholariq.org/papers/genomic-landscape-and-tumor-mutational-burden-determination-of-circulating-tumor/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)

## Researcher university

- [Qingdao University](https://scholariq.org/institutions/qingdao-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.